Fundraising Fox
Stephen Knight
InvestorPresident and Managing Partner at F-Prime Capital
Cambridge, Massachusetts
Writes $100K – $10M checks · typically $5M
Find your path to Stephen
Sign up to see every warm intro you have to Stephen
- Paths you didn't know you had: your email and LinkedIn already hold routes to Stephen. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Stephen Knight is a Yale-trained MD/MBA physician-investor with Bell Labs and NIH roots and biotech operating experience who co-founds platform companies and works with academics to spin out science.
Contact· self-published, not guessed
Invests in
BiotechCrypto & Web3FintechHealthtechMedical Devices
Investments
Board seats
Investor
Aerium TherapeuticsAtalantaBlueprint MedicinesEnsomaGenomicsLeyden LabsParadigmPrime MedicineQuantum Circuits
Sources: SEC Form D filings · curated public sources.
Colleagues at F-Prime Capital
Network2
Investors connected to Stephen in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Stephen Knight?
- Stephen Knight is a Yale-trained MD/MBA physician-investor with Bell Labs and NIH roots and biotech operating experience who co-founds platform companies and works with academics to spin out science.
- Where does Stephen Knight work?
- Stephen Knight is President and Managing Partner at F-Prime Capital.
- What does Stephen Knight invest in?
- Stephen Knight invests in Biotech, Crypto & Web3, Fintech, Healthtech, Medical Devices.
- What check size does Stephen Knight write?
- Stephen Knight typically writes checks of $100K – $10M.
- What boards does Stephen Knight sit on?
- Stephen Knight holds tracked board seats at Ensoma.
- What companies has Stephen Knight invested in?
- Investments tracked here include Aerium Therapeutics, Atalanta, Blueprint Medicines, Ensoma, Genomics, Leyden Labs, Paradigm, Prime Medicine, Quantum Circuits.
About this profile. Compiled from public sources — F-Prime Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights